SREBF1 and metabolic dysfunction-associated steatotic liver disease: In this study, we evaluated the interventional effect of EMZAP by inducing the NAFLD mouse model with a high-fat diet and analyzed the genes associated with fatty acid synthesis (SREBP-1c) and oxidation (PPARα, ACOX-1, CPT-1) to explore the hypolipidemic mechanism.